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Abstract 
The administration of sliding scale insulin continues to be the primary form of glycemic 
management used in hospitals for the management of hyperglycemia in patients with diabetes. 
However, basal-bolus insulin regimens have been demonstrated by research to create more 
advantageous patient outcomes than sliding scale insulin. The purpose of this pilot study is to 
identify perceived barriers among nursing staff regarding implementation of a basal-bolus insulin 
standard for the management of inpatient hyperglycemia in hospitals and test a mixed-methods 
survey for future quantitative research. The survey tool was designed to obtain unique, self-
reported information from practicing inpatient nurses and collect data regarding nurse confidence 
and familiarity with different types of insulin administration. A convenience sample of nurses 
from two units in a major medical center was surveyed electronically based upon principles used 
in similar previous research involving providers. Results indicate that nurses report lower levels 
of confidence with administration of multiple insulin types than with sliding scale insulin, and 
that they place a high priority on glycemic treatment and preventing hypoglycemia in patients. 
Results also indicate that fear of medication errors and causing hypoglycemia were primary 
nursing barriers among those surveyed. Identified response themes and common barriers have 
implications for future research, as well as education and policy efforts undertaken by medical 
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Introduction 
In 2014, 29.1 million people in the United States had diabetes in some form, and Type 2 
diabetes mellitus accounts for 90-95% of total diagnosed cases of diabetes (Centers for Disease 
Control and Prevention [CDC], 2014). The administration of sliding scale insulin (SSI) continues 
to be used as a primary form of glycemic management in hospitals for patients with diabetes: 
however, a basal-bolus insulin (BBI) regimen works to more closely mimic the body’s natural 
insulin production and release systems, and research has demonstrated that BBI is associated 
with more advantageous patient outcomes (Umpierrez et al., 2007; Lee et al., 2015). Despite this, 
surveys of provider perceptions surrounding insulin protocols have indicated that SSI regimens 
are often considered a less complex, and more comfortable, choice of glycemic management 
protocols by providers when compared to BBI regimens (Cheekati, Osburne, Jameson, & Cook, 
2009; Latta et al, 2011). While research into provider comfort levels exists, limited data is 
available with regard to the comfort level and potential barriers of nursing staff to the 
implementation of a basal-bolus protocol as standard hospital policy for the treatment of 
hyperglycemia. 
The purpose of this study is to identify and explore perceived barriers to implementing a 
BBI dosing standard for the management of inpatient hyperglycemia in hospitals. This initial 
research is designed to obtain unique, self-reported, quantitative and qualitative information from 
practicing inpatient nurses in order to examine nurse confidence and familiarity with different 
types of insulin administration. This study further seeks to determine the validity of a future, 
strictly quantitative survey. By using both open ended question and quantitative formats, this 
initial study allows nurses to self-report their experiences and primary concerns regarding 
hyperglycemia management in hospitals. Analysis of responses supports the identification of 
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common trends and similarities to prior, provider-focused research on implementation barriers, 
as well as the identification of nursing-specific barriers and potential opportunities for education. 
Results will be used to design and implement a more comprehensive quantitative survey for the 
purpose of surveying a larger, broader population of nurses, in order to validate and expand on 
the results of this survey and collect meaningful data that can guide future policy change 
protocols and education efforts in hospitals. 
Background  
According to statistics released by the Centers for Disease Control and Prevention in 
2014, 29.1 million people in the United States have diabetes in some form. Of those, nearly a 
third who are living with diabetes (8.1 million people) are undiagnosed (CDC, 2014). Type 2 
diabetes mellitus (T2DM) accounts for 90-95% of total diagnosed cases of diabetes, with Type I 
diabetes mellitus (T1DM) accounting for the remaining 5-10% (CDC, 2014). The cost of 
diabetes treatment in the U.S. in 2012 was estimated at $245 billion dollars, with $68 billion of 
that cost being represented by lost work, disability, and premature death (CDC, 2014).  
Much of the cost of diabetes can be associated with the comorbid conditions related to 
the disease. Diabetes significantly increases the risk of hypertension, heart disease, stroke, 
kidney disease, neuropathy, retinopathy, and lower limb amputations especially if the diabetes is 
not adequately managed (CDC, 2014; Clement et al., 2004). Numerous studies have found that 
inpatient control of hyperglycemia improves hospital outcomes by reducing prevalence of T2DM 
comorbidities, shortening patients’ length of stay, and reducing diabetes-associated mortality 
(Clement et al., 2004; Cheekati et al., 2009; Garber et al., 2016).  
Most patients with T2DM require insulin administration for glycemic control while being 
treated in an inpatient hospital setting, and the choice of insulin administration protocols can 
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have a large impact on patient outcomes (Browning, 2004). Subcutaneous insulin administration 
is the most prevalent form of glycemic control used in hospitals, and consists of sliding scale 
(correctional only) or basal-bolus (basal plus nutritional insulin coverage) protocols. However, 
while SSI is the most widely used protocol for glycemic control in non-critical patients, research 
has demonstrated that it is a far less advantageous practice when compared to BBI regimens 
(Umpierrez et al., 2007; Lee et al., 2015). 
Sliding Scale versus Basal-Bolus Treatment 
 The administration of SSI regimens, also referred to as correctional or correctional-only 
insulin, has been used as a glycemic management method since its introduction to practice in 
1934 (Nau, Lorenzetti, Cucuzzella, Devine, & Kline, 2010). The protocol traditionally requires 
that patients receive pre-prandial and pre-bedtime finger-stick blood glucose testing if they are 
eating, or testing every six hours if they are not, with the results being used to calculate the 
amount of insulin needed to regulate the patient’s blood glucose within acceptable ranges. The 
ADA currently recommends a blood glucose range of between 140-180 mg/dl for hyperglycemic 
patients receiving insulin treatment. Tighter ranges, sometimes as low as 80-110 mg/dl, had 
previously been recommended but research has shown no benefit in most populations to 
maintaining blood glucose levels below 140 mg/dl (ADA, 2016). SSI protocols typically do not 
take into account a patient’s basal insulin needs, diet, or other patient-specific modifiers to 
insulin need (such as insulin sensitivity) when determining the amount of insulin to provide, and 
are considered to be a reactive, rather than proactive, approach to blood glucose management 
(Nau et al., 2010).  Sliding scale regimens can lead to rapid changes in blood glucose levels in 
patients; prolonged or intermittent hyperglycemia despite insulin treatment; hypoglycemia 
related to insulin stacking or unexpected alterations in nutritional intake or activity levels; and 
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less advantageous outcomes, such as higher incidence of infection and longer hospital stays for 
patients (Hassan, 2007; Browning, 2004). 
In contrast to SSI’s reactive treatment methodology, a basal-bolus insulin regimen works 
to more closely mimic the body’s natural insulin production and release systems. A ‘basal’ 
insulin dose is provided through use of long acting insulin, such as glargine, which has no peak 
over its duration, an onset of 2-4 hours, and lasts for 24 hours (Datta, Qaadir, Villanueva, & 
Baldwin, 2007). A bolus of rapid-acting insulin can then be given prior to meals (nutritional 
insulin) in order to cover oral carbohydrate intake, and on a correctional basis, to cover higher-
than desired pre-prandial blood glucose readings (American Diabetes Association [ADA], 2016; 
Datta et al., 2007).  This manner of insulin dosing more closely mimics the body’s natural 
production and release of insulin by the pancreas, and is structured in such a way to proactively 
address blood glucose fluctuations before they occur rather than treating them retroactively. 
Though SSI is still widely used in healthcare settings, extensive research has 
demonstrated that the BBI approach is a superior treatment methodology when it comes to 
creating more advantageous patient outcomes. One study of 130 insulin-naïve patients with 
T2DM in an inpatient setting compared the administration of once-daily glargine and glulisine, a 
basal-bolus regimen, given prior to meals to a four-times-daily sliding scale administration. The 
study found that the BBI group saw significantly better blood glucose control than the SSI group, 
with approximately 67% of the basal-bolus group reaching and maintaining blood glucose targets 
as compared to approximately 33% of the sliding scale group. Additionally, 14% of SSI group 
patients had consistently-elevated blood glucose levels despite increased insulin administration, 
but rapidly improved their glycemic control when switched to the glargine-glulisine regimen 
(Umpierrez et al., 2007).  
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 Another study conducted in 2007 compared the use of glargine, a basal-only protocol, 
every 24 hours to a SSI protocol administered every six hours in patients who were status-post 
gastric bypass surgery (Datta et al., 2007). The study found that the basal group showed an 
increased level of blood glucose control over the SSI group, with 53% of basal patients meeting 
blood glucose targets in contrast to the 36% of SSI patients who met targets. The study also 
found no increased incidence of hypoglycemia among the basal group (Datta et al., 2007).  
More recent studies and meta-analyses of SSI versus BBI treatment plans have continued 
to conclude that basal-bolus is the superior treatment method for hospital patients with 
hyperglycemia. One meta-analysis by Lee and colleagues in 2015 concluded that mean blood 
glucose levels and incidence of hyperglycemia were significantly higher in patients treated with 
SSI than those treated with BBI regimens, and that there was no increase in severe hypoglycemia 
incidence among BBI patients. Their research led them to conclude that SSI “[does not provide] 
any benefits in blood glucose control,” and that SSI use should be discontinued in hospitals 
entirely (Lee et al., 2015). 
Standards of care 
The ADA recommendations for inpatient care of patients with diabetes conforms to the 
evidence that SSI use in hospitals is not the preferred treatment option for inpatient glycemic 
control. In their 2016 Standards of Care, the ADA recommends the following in relation to 
insulin therapy for blood glucose control during inpatient hospital stays: 
 A basal plus bolus correction insulin regimen is preferred for non-critically ill 
patients with poor oral intake or who intake nothing by mouth. 
 A basal plus bolus insulin with nutritional and correctional components is 
preferred for patients with good oral intake. 
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 The threshold for initiation of insulin therapy to treat sustained hyperglycemia is 
≥ 180mg/dl, with a target range for blood glucose between 140-180mg/dl.  
 The sole use of sliding scale insulin for inpatient glycemic control is strongly 
discouraged. 
(ADA, 2016) 
The American Association of Clinical Endocrinologists (AACE) additionally have their 
own recommendations for insulin management of type 2 diabetes, with the following key points: 
 Patients with A1C >8.0% or long-standing type 2 diabetes, a single daily basal 
dose of insulin is recommended to meet blood glucose targets. Basal insulin 
dosage should be adjusted at regular and fairly short intervals to achieve targets 
without hypoglycemia. 
 Basal insulin analogs are preferred to NPH insulin for basal dosing. 
 Patients on basal insulin whose blood glucose is still not adequately controlled 
may require mealtime bolus insulin in addition to basal dosing. Rapid-acting 
insulin types are preferred to regular types for mealtime bolus dosing. 
 A full basal-bolus plan is the most effective insulin regimen. 
 Hypoglycemia avoidance is critically important due to increased risk of death and 
adverse outcomes among patients with a history of one or more severe 
hypoglycemic events. 
(Garber et al., 2016) 
Analysis of Potential Barriers 
 The standards of care recommended by the ADA and the AACE and the overwhelming 
consistency of research data demonstrate a BBI regimen as the preferred treatment for inpatient 
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hyperglycemic control. However, SSI use as a standard treatment protocol or hospital policy is 
still widespread. This indicates that practice barriers to implementation of BBI may exist within 
the healthcare industry. 
Previous Research 
 Several surveys of medical residents have investigated knowledge, comfort level, and 
barriers among providers in relation to management of inpatient hyperglycemia. These studies 
have found that the most common barrier to effective care using basal-bolus insulin regimens 
over SSI protocols listed by providers were perceived risk of hypoglycemia, often related to the 
unpredictability of patient mealtimes and scheduled procedures, and lack of knowledge of the 
most effective insulin regimen (Latta et al., 2011; Cheekati et al., 2009).  However, when also 
asked why they thought sliding scale was still used, 43% of providers surveyed indicated it was 
due to physician unfamiliarity with ordering nutritional and basal insulins (Latta et al., 2011).  
Only 33% of providers surveyed in one study in 2011 knew that aspart, a rapid-acting insulin, 
peaks in 45 to 90 minutes, and only 38% of providers in the same study knew that basal dosing 
must be adjusted to correct fasting blood glucose levels rather than oral intake (Latta et al., 
2011). Similarly, a 2009 study of urban hospital medical residents found that 50% or more of the 
providers surveyed indicated they were “somewhat comfortable” or “not at all comfortable” with 
treating hyperglycemia in general, with the same level of comfort reported in over half of 
providers with regard to ordering insulin (Cheekati et al., 2009). 
This research additionally indicates that provider comfort with overall hyperglycemia 
management principles is directly related to physicians’ choice to order SSI rather than BBI for 
patients: 65% of respondents who were ‘somewhat comfortable’ with managing hyperglycemia 
said they would use SSI in “difficult to control blood glucose,” with only 30% of respondents 
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who considered themselves “very comfortable” with hyperglycemia management reporting the 
same (Latta et al., 2011). These results were corroborated by personal interactions with active 
diabetes-focused hospital personnel, who indicated physician comfort level in ordering insulin 
and general understanding of different insulin types; appropriate order sets and monitoring 
practices; and fear of hypoglycemia were all factors in physician resistance to a change in insulin 
policy (J. Swift, personal communication, October 6th, 2016; A. Goley, personal communication, 
October 11, 2016). These research results establish that SSI regimens are often considered a 
safer, or more comfortable, choice of glycemic management protocols for providers when 
compared to basal-bolus insulin regimens, despite being less effective in controlling 
hyperglycemia. 
Potential Nursing Barriers 
 When asked to identify the largest barriers to better management of inpatient 
hyperglycemia, medical residents in a 2011 survey indicated that variability in patient diet, 
mealtime and procedure timing; hypoglycemia risk; and knowledge of the situational 
appropriateness of different insulin protocols ranked among the top responses (Latta et al., 2011). 
All of these top responses are potentially relevant to nursing staff behaviors. A diabetes 
education specialist indicated that fear of hypoglycemia; lack of understanding of dosing 
protocols; and dosing time requirements for different insulin types appear to have a large role in 
nurses’ lack of confidence with basal-bolus regimens (J. Swift, personal communication, October 
6th, 2016). It was additionally indicated that patient meal timing and the timing of procedures 
contributed to nurses’ discomfort with administering non-correctional insulin types (J. Swift, 
personal communication, October 6th, 2016). Many nurses were confused as to the difference 
between nutritional (bolus) and correctional insulin (SSI), and indicated to the diabetes education 
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specialist that they would hold nutritional insulin based on a pre-prandial blood glucose reading 
below 100 mg/dl, regardless of patient meal status or correctional insulin orders (J. Swift, 
personal communication, October 6th, 2016). This behavior may be related to lower confidence 
in administering complex insulin regimes, or confusion surrounding terminology associated with 
insulin types.  
While research into provider comfort levels in prescribing insulin and potential prescriber 
barriers to basal-bolus insulin procedures exists, limited scholarship is available with regard to 
the comfort level and potential barriers of inpatient nursing staff and BBI regimens. Given that 
nurses directly administer insulin at the bedside and possess the capability to make decisions 
regarding how and when to administer or hold insulin to patients based on clinical judgement, 
ascertaining whether the similar levels of discomfort and perceived barriers to BBI use exist 
among nurses could aid in the design of comprehensive targeted education and changes to 
existing policy. Additionally, through examination of nurse self-reporting of potential barriers, 
evidence of challenges in BBI administration that are unique to the nursing role can potentially 
be discovered.  
Research Design and Methods 
Design  
A mixed-methods design was chosen for this study in order to pilot, refine, and establish 
the validity and reliability of the survey instrument, as well as to obtain rich and valuable data for 
future studies. Quantitative questions in the survey’s first section preceded the open ended, 
qualitative questions in the survey’s second section, with the final section being comprised of 
demographic questions. There are a total of 21 questions in the survey, and participants are 
expected to take approximately 15 minutes to complete the survey, though many completed the 
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survey in less than five minutes. The survey tool is based on previous research regarding 
provider comfort with insulin ordering (Cheekati et al., 2009; Latta et al., 2011). Similar to 
previous provider studies, quantitative questions were asked to indicate nurses’ comfort levels 
with insulin administration and measure their perceptions of treatment importance. Demographic 
data was also collected in this format. These measures were included for ease of data analysis 
and comparison, as well as to test the reliability of a quantitative question format for future 
research.  
The use of open questions that individual participants may respond to with their own 
perceptions was added to previously-used survey design to gain insight into potential barriers or 
challenges that most influence individual nursing practice. By allowing nurses to dictate their 
own unique responses, trends can be more-easily identified, and responses can be used to tailor 
future quantitative questions that better target specific barriers in research using more 
participants and a quantitative study design. 
The inpatient hospital setting was chosen for survey administration in order to most 
appropriately address the research question: what are the specific barriers for staff nurses to the 
institution of a basal-bolus protocol as standard practice in major medical centers? In 
partnering with medical center research administration, nurse managers on units surveyed were 
identified as the most effective distributors of the questionnaire in order to increase awareness of 
the survey among nursing staff and increase response rates. Though involving nurse managers as 
survey distributors potentially impacts nurse reporting through concern for job repercussions, the 
electronic survey was designed to maintain confidentiality of survey participants, and all data 
released to nurse managers and hospital administrators was grouped in order to preserve 
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anonymity for individual respondents. An electronic format was chosen for participant 
convenience, and to facilitate rapid, accurate data collection.  
Sampling 
 Convenience sampling methodology was used by administering the survey to inpatient 
nurses on two hospital units through cooperation with hospital administration. Nurses received 
the survey electronically through email via their nurse managers, and participation in the survey 
was completely voluntary. Though the types of patients cared for varied by unit, participants 
represented a fairly homogenous sample of inpatient medical/surgical nurses within a single 
hospital environment. The small size of the sample will affect the nature and scalability of 
results; however, the population of nurses surveyed is closely representative of the population 
that will be targeted by future intervention efforts related to insulin administration education and 
policy. Further, the units chosen represented enough diversity in patient care that results related 
to survey design and the effectiveness of the question format will have a high likelihood of 
scaling to a larger nursing population in a more diverse selection of inpatient units. All survey 
respondents were included in the final data set. 
Data Collection Instrument 
The survey tool used in this project considered principles evident in the modified Mayo 
Clinic Inpatient Diabetes Attitude Survey used in Cheekati, Osbourne, Jameson, and Cook’s 
2009 study on resident physicians at an urban hospital. By using background from this and other 
similar studies, questions were tailored to examine the level of importance nurses place on 
treating hyperglycemia and avoiding hypoglycemia, as well as nurse comfort level with treating 
hyperglycemic patients and with administering insulin of various types. An additional question 
regarding comfort level with insulin terminology was added based on indications from endocrine 
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and diabetes education staff.  Questions on comfort level were formatted similarly to those used 
for providers in previous studies (Cheekati et al., 2009).  
In addition to the multiple-choice questions, questions were also developed to allow free 
answer responses, allowing nurses to discuss their concerns for patients receiving insulin, the 
administration of insulin, and how those concerns potentially affect the nursing care they 
provide. Additional questions were included regarding nurses’ interactions with providers 
regarding insulin orders. These questions were developed to ascertain whether communication 
with providers was seen as a potential barrier to nurses’ confidence in managing insulin regimes. 
Finally, demographic questions regarding the nurses’ work environment were asked, including 
normal shift, type of unit, level of nursing education, and years of nursing experience in order to 
track possible response trends among groups working similar shifts or on similar units.  The 
survey tool can be viewed in Appendix A. 
Research Participants and Data Collection Procedures  
 The survey was administered at a large university medical center for 13 consecutive days 
after obtaining approval for the project through both the Institutional Review Board and the 
facility Nursing Research Council. Two hospital units participated in the survey; a 
medical/surgical unit catering to general medicine and renal patients, and an acute care cardiac, 
vascular, and thoracic surgery unit. 
Survey recruitment was done through standardized email message sent through the nurse 
managers on both units. Each email contained a consent information and disclaimer that 
individual respondent data would not be collected and that participants would be safe from job 
repercussion. The recruitment emails contained a general, anonymous login link to the electronic 
survey, powered by Qualtrics.  A follow-up reminder message was sent one week after the initial 
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email was distributed by unit nurse managers. Examples of survey messages can be viewed in 
Appendix B. 
Data Analysis 
 Survey results were collected as soon as they were completed through Qualtrics online 
survey tools, with quantitative question data from individual survey responses grouped and 
compared to demographic responses using the same system. Qualitative responses were 
examined individually in order to identify trends in responses, and then coded to quantitative 
topic groups based on individual concepts or assertions within responses. Some responses were 
coded into multiple topic groups based on content. Coded responses were then compared to other 
quantitative questions and demographic data in order to identify response trends. Both the PI and 
the Advisor coded and reviewed the data and agreed upon the quantitative data and results as 
well as qualitative categories. Qualitative responses were categorized both for data analysis and 
results with regard to this pilot study and for use in future quantitative research. 
Results 
Demographic Data 
 A total of 25 nurses across the two units responded to the survey. The respondents were 
asked to specify the type of unit they worked on through free text rather to protect anonymity of 
the units surveyed from participants. Participants who responded with variants of “acute care,” 
“heart and vascular,” “cardiac,” or the name of the cardiac unit were sorted into “Acute Care”, 
and those who responded with “medicine,” some variant of “medical/surgical,” or the name of 
the medical/surgical unit were sorted into “Medical/Surgical.” A total of 16 respondents (64%) 
reported they worked in “Acute Care”, seven (28%) reported they worked in a 
PERCEIVED BARRIERS AMONG NURSING STAFF TO BASAL-BOLUS     15 
“Medical/Surgical” unit, and two (8%) responded with “inpatient” and could not be sorted into 
either unit. 
The majority of nurses surveyed reported having between 1-3 (24%, n=6) years or 5-10 
years (32%, n=8) of nursing experience, with 16% (n=4) surveyed reporting 3-5 years or greater 
than 10 years respectively, and three respondents (12%) being within the less than one year new 
graduate period. Twenty respondents (80%) reported a Bachelor’s of Science in Nursing (BSN) 
degree as their highest level of education; two respondents (8%) had an Associate’s Degree in 
Nursing (ADN), and three (12%) reported a Master’s Degree (MSN) as their highest level of 
education. The majority (56%, n=14) of respondents primarily worked day shift, with 24% (n=6) 
reporting night as their primary shift, and 20% (n=5) primarily working rotating shifts. These 
results can be viewed in Appendix C. 
When comparing demographic identifiers of the sampled population, it became notable 
that survey participants with either an ADN or MSN all reported at or greater than three years of 
nursing experience.  Experience categories were fairly evenly distributed among individual units, 
though nurses who worked on the Medical/Surgical unit were more likely to have a greater level 
of experience, with 57.14% (n=4) reporting 5 or greater years of experience as compared to 
43.75% (n=7) from the Acute Care unit. With regards to experience level and shift type, less 
experienced nurses were much more likely to work night or rotating shifts, with 40% (n=2) of 
rotating shift and 50% (n=3) of night shift respondents reporting three or less years of nursing 
experience. 
Perception of Treatment Importance 
 Overwhelmingly, surveyed nurses indicated that they believed treatment for patients with 
diabetes is of high priority, with 96% (n=24) of respondents indicating treatment of 
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hyperglycemia was “very important.” Additionally, 100% (N=25) of respondents indicated that 
preventing hypoglycemia in patients receiving insulin was likewise “very important.”  
Perceived Confidence as a Barrier to Insulin Administration 
Surveyed nurses reported a higher degree of confidence regarding the administration of 
sliding-scale insulin when compared to confidence administering multiple insulin types. The 
broad majority (92%, n=23) of respondents indicated that they were “very confident” in 
administering insulin on a sliding scale/correctional protocol, with the remaining 8% (n=2) 
indicating that they were “somewhat confident.” No respondents indicated that they were unsure 
or not confident at all in using SSI alone. However, when asked to rate their comfort in 
administering multiple types of insulin to a single patient, including basal and bolus insulins in 
the same shift, only 60% (n=15) of respondents indicated that they were very confident, with the 
remaining 40% (n=10) indicating they were somewhat confident.  
When examined in relation to demographic data, confidence in administering sliding 
scale insulin was linked to experience, with all participants who were only “somewhat confident” 
in administering SSI having less than three years of nursing experience; 33.33% (n=1) of new 
graduates were somewhat confident in SSI administration, and 16.67% (n=1) of nurses with 1-3 
years of experience rated themselves “somewhat comfortable.” Education level did not show any 
significant relation to SSI comfort, though differences between units was observed, with only 
87.5% (n=14) of nurses working in the acute care unit rating themselves as “very confident” in 
administering SSI compared to 100% (n=7) in the medical/surgical unit.  
In contrast, greater amounts of nursing experience were not consistent with a higher 
degree of confidence in administering multiple insulin types. New graduate nurses unilaterally 
rated themselves “somewhat confident” in administering multiple insulin types (n=3), with 50% 
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(n=3) of those with 1-3 years of nursing experience rating themselves the same way. As with 
SSI, 100% (n=4) of respondents with 3-5 years of experience rated themselves as “very 
confident” in administering multiple insulin types; however, the level of confidence dropped in 
nurses with greater than five years of experience. Nursing veterans (5-10 years) generally rated 
themselves “very confident” (75%, n=6), but only 50% (n=2) of respondents with greater than 
ten years of experience rated themselves the same way. A comparison of these results can be 
viewed in Figure 1. 
 
When broken down by shift, nurses working a rotating shift expressed the greatest change 
in confidence between administering insulin types, with 80% (n=4) of rotating shift respondents 
rating themselves “very confident” in administering SSI, and the same number (80%, n=4) then 
indicating that they were only “somewhat confident” with administering multiple insulin types. 
These results can be viewed in Appendix D.  
There was no significant indication that confidence in administering insulin was affected 
by unit. With respect to education, non-BSN nurses had the highest confidence, with ADN and 
MSN nurses rated themselves as “very confident” 100%  of the time (n=2; n=3) with all insulin 
types.  In contrast, BSNs reported lower confidence with multiple insulin types, with only 50% 
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(n=10) responding “very confident” for multiple insulin types, compared to 90% (n=18) 
responding the same for SSI. 
Percieved Confidence Related to InsulinTerminology 
When asked how confident they were with terminology used to describe different 
methods of insulin administration, surveyed nurses were split, with 52% (n=13) rating 
themselves “very confident,” 44% (n=11) rating themselves “somewhat confident,” and 4% 
(n=1) reporting that they were not at all confident in understanding and using insulin 
terminology. While responses did not differ significantly by work unit or education level, results 
indicate a significant correlation between what shift respondents normally work and their level of 
confidence with insulin terminology, with day shift reporting substaintially more confidence than 
night or rotating shift respondents. These results can be viewed in Table 1. 
 
Nursing experience level showed a similar results distribution to that reported in regards 
to administration of multiple insulin types, with the largest proportional number of “very 
confident” responses belonging to those with 3-5 years of experience and lessening confidence 
indicated with both less and more nursing experience.  These results can be viewed in Figure 2, 
as well as Appendix E. 
PERCEIVED BARRIERS AMONG NURSING STAFF TO BASAL-BOLUS     19 
 
Reported concerns for patient care 
  Insulin Administration concerns 
 When asked what their greatest concern is when administering insulin to a patient, the 
responses surveyed nurses provided identified themes in perception regarding insulin among 
inpatient nursing staff. In examining responses, common themes were grouped into key phrases 
for the purpose of identifying factors that may drive nurse perception of BBI administration 
barriers. The 23 provided responses were assigned seven headings, with some responses assigned 
to multiple headings based on content.  These results can be viewed in Table 2.  
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“Hypoglycemia” and “med error” were the largest identified concern categories, and 
were indicated as concerns collectively in 69.56% (n=16) of responses. Individual responses 
included general concerns such as “causing hypoglycemia,” as well as more specific concerns, 
including fear of basal insulin at night causing hypoglycemia in the morning; patients with 
“brittle” diabetes; administration of the wrong dose or wrong type of insulin; and making a 
medication error while fatigued.  The “correct treatment” category included concerns regarding 
the patient’s individual response to insulin, as well as concern for patients with newly diagnosed 
diabetes and their need for “a lot of adjustment with insulin.” 
 Concerns regarding “dosage timing” and “dietary intake” collectively represented the 
second largest category of responses (34.78%, n=8), and responses within the two categories 
often overlapped, encompassing concerns regarding administering SSI prior to a patient’s food 
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tray arriving; the timeliness of blood sugar checks in relation to meal arrival; patients not eating 
when expected; and “large Lantus doses when [the patient is] not eating much.”  
Administration concerns differed substantially based on survey responder demographics, 
with different units indicating different priorities. The Acute Care unit showed the greatest 
concern for the “hypoglycemia” and “med error” categories; in contrast, the Medical/Surgical 
unit was most concerned with whether the patient was receiving the correct treatment. These 
results can be viewed in Appendix F. 
Priorities differed across education levels as well: ADN’s only reported concerns were 
“dietary intake” and “dosage timing,” while MSNs only reported “hypoglycemia” and “med 
error” as chief considerations. BSNs were split more evenly between all categories, though “med 
error” was the most significant concern, represented in 38.89% of responses (n=7). 
  Most significant was how primary concerns shifted as nursing experience increased. 
While less experienced nurses were primarily concerned with making medication errors, with 
40% of responses for new grads (n=2) and 57.14% of responses for nurses with 1-3 years of 
experience (n=4) in the “med error” category, only 20% (n=2) of nurses with greater than 5 years 
experience indicated “med error” as a primary concern, and no nurses with over 10 years of 
experience indicated it at all. For veteran nurses, the patient’s dietary intake was their chief 
concern (40%, n=2), with “dosage timing,” “correct treatment,” and ensuring accurate blood 
glucose monitor readings being their only other listed concerns. These results are displayed 
graphically in Figure 3, with numeric results displayed in Appendix G. 
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Overall concerns 
When asked to respond with their greatest overall concern for their patients receiving 
insulin, surveyed nurses responded differently and in a more detailed fashion than with the 
individual concern question. Yet, 52% of responses (n=13, N=25) still indicated “hypoglycemia” 
as a significant overall concern, and hypoglycemia concerns overlapped heavily with responses 
indicating concerns of “dietary intake,” “correct treatment,” and “med error.” Discrepancies in 
home treatment and hospital care for patients with diabetes were often associated with concerns 
regarding education and patient compliance with treatment. Responses additionally indicate that 
uncertainty from patients who take oral anti-hyperglycemic agents at home and are switched to 
insulin therapy in the hospital leads to the perception of problems with treatment. Results can be 
viewed in Table 3.  
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Demographic responses impacted reported overall concerns heavily. As with 
administration concerns, units displayed different priorities: the Acute Care unit indicated 
“hypoglycemia” as the primary overall concern (41.67%, n=10); in contrast, the 
Medical/Surgical unit indicated concerns relating to patient home treatment and discharge 
planning, with “home vs hospital treatment” occupying the largest proportion of responses 
(44.44%, n=4). 
With regard to experience level, “hypoglycemia” and “med error” were primary concerns 
for less experienced nurses, with both concerns represented in greater than 40% of responses for 
nurses with between 1-5 years’ experience and 80% (n=4) of new graduate responses. However, 
while hypoglycemia concerns were well represented in responses from the 5-10 year experience 
group, “med error” concerns diminished as experience grew, with no nurses with greater than 5 
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years of experience indicating it as a primary concern. Veteran nurses with greater than 10 years’ 
experience were most concerned with whether their patients were receiving the right treatment. 
These results are displayed graphically in Figure 4.        
 
 When asked how the listed concern affects their overall nursing care, surveyed nurses 
primarily indicated that it would cause them to exercise extra caution or double-check 
themselves when providing care to these patients (42.86%, n=9), or that the concern would cause 
them to focus on educating the patient (38.10%, n=8). Responses from those indicating their 
greatest overall concern would cause them to be more cautious in their care included double-
checking medicine doses and dietary considerations before administering insulin, being 
conservative with insulin administration for NPO or vomiting patients, and checking on patients 
more frequently. 
 
Perceptions of Provider Feedback 
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 Surveyed nurses were asked if they had ever given a provider feedback regarding an 
insulin order, and were asked to clarify what the feedback was if an affirmative response was 
given. Out of 25 respondents, 24 (96%) indicated that they had given feedback to a provider 
regarding an insulin order.  
When asked to elaborate on what feedback was given, responses primarily focused on 
requests for modifications to orders based on patient care concerns, asking for clarification, or 
requesting provider support for education or requesting a consult. As with responses regarding 
concerns for insulin administration, responses were grouped into categories, with some responses 
falling in to multiple categories based on content.  
 The primary reason nurses reported that they contacted providers regarding insulin 
orders was to inquire about the appropriateness of the ordered dose, with 57.14% (n=12) of 
responses involving this category. “Clarification of communication” was separated from 
“requesting a modification to an order”, which was the second most prevalent reason reported at 
38.10% (n=8) of responses. Other reasons for provider communication reported by survey 
respondents include requesting endocrine service consults, requesting that the provider perform a 
function in patient education, and concerns for differences between patients’ home and hospital 
treatment plans. 
Further analysis on responses included whether the communications explicitly indicated 
they were concerned with basal insulin orders or sliding scale orders. Of the total 21 (42.86%) 
responses, nine explicitly mentioned “basal insulin,” “Lantus,” or “glargine,” with only three 
responses (14.29%) explicitly mentioning “sliding scale,” “SSI,” or specific insulins used in 
sliding scale or correctional protocols. However, many responses did not specify the type of 
insulin order in their response, and therefore nine responses (42.86%) fell into neither category. 
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As a second follow-up, respondents were asked to describe how the provider responded 
when they contacted them for the purpose of assessing perceptions of surveyed nurses regarding 
communication with providers as a potential barrier. Responses were categorized as “positive,” 
“negative,” or “mixed” based on content. Responses such as “changed the order,” “positively,” 
and “well received” were considered “positive”, with answers such as “can’t you just call the 
diabetes educator,” representing “negative” feedback. “Mixed” responses often contained the 
words “mixed” or “depends.” Overwhelmingly, surveyed nurses indicated that they received a 
positive response from providers when they reached out regarding insulin orders, with 17 of 21 
responses (80.95%) indicating a “positive” response, and only one response (4.76%) indicated a 
strictly “negative” provider response. Three responses (14.29%) were mixed. 
Respondents were then asked if they had ever wished to give providers feedback, but 
chosen not to do so. This was asked in order to further examine potential reservations regarding 
contacting providers. Of 24 responses, five (20.83%) indicated that they had wanted to give 
feedback to a provider, but had chosen not to. However, when asked in follow-up what the 
feedback was, only two responses were given, and both represented concerns regarding the 
appropriateness of order insulin dosing. Of these respondents who answered the follow-up, only 
one answered a second follow-up question regarding the reason why they chose to hold their 
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Confidence with basal-bolus administration and terminology  
Study data demonstrates that surveyed nurses are significantly less confident in 
administering multiple insulin types, including basal and bolus insulins, than they are in 
administering SSI. These results are similar to research done regarding provider confidence, 
where lower confidence levels in treating hyperglycemia in general correlated to higher ordering 
of SSI (Latta et al., 2011).  
In particular, results suggest that a prevalent concern among inpatient nurses surveyed is 
causing hypoglycemia as a result of inappropriate insulin administration. In individual responses, 
many nurses indicated how they would modify their behavior surrounding insulin administration 
in an attempt to prevent hypoglycemic events. Examples of responses include: 
“I may be more conservative when giving insulin to patients especially those who are 
NPO.” 
“I have concerns when I am administering a large amount of SSI to pts when their 
food tray is not readily available, even when their BS is high.” 
“[Concern regarding] food intake, large Lantus doses when not eating much.” 
The relationship between food availability and insulin administration was common in 
responses, both with regard to SSI administration and when nurses were discussing basal insulin. 
The lack of consistency respondents indicated regarding how to handle basal insulin in situations 
where patients had poor oral intake was apparent in responses regarding communications with 
providers, many of which included asking for clarification or modification of basal doses. 
Examples include:  
“Suggested that the MD hold the patient’s scheduled insulin glargine because of a 
low blood sugar or cutting the dose in half.” 
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“To adjust the dosages of long-acting insulins when patients will be NPO after 
midnight.” 
“Clarify amount of Lantus insulin to be administered when patients are NPO for 
tests/procedures.” 
“[Asked MD] about basal loading doses.” 
“I clarified the dose of basal insulin since the patient was NPO after midnight for a 
procedure in the morning. The prescriber adjusted the dose by decreasing it.” 
It is important to note that the ADA recommends basal plus correctional protocols for 
patients who are receiving nothing by mouth or have poor oral intake, primarily contradicting the 
perception evident in individual survey responses that patients require reduction or elimination of 
basal insulin in these situations. ADA guidelines indicate prevention of hypoglycemia in these 
patients is better achieved through the reduction or elimination of nutritional insulin, which is 
explicitly related to oral intake, while basal insulin is not (ADA, 2016). 
Survey results also indicate that education is a factor in respondent’s confidence levels 
when administering multiple insulin types: nurses with less than three years of experience show 
similar confidence levels to nurses with greater than five years of experience, both of which are 
lower than confidence levels reported by nurses with 3-5 years of experience. This indicates that 
the confidence gained with increased professional experience may be counteracted by a greater 
amount of time passing since completion of formal nursing education in more experienced 
nurses. These conclusions are further supported by results relating to confidence with insulin 
terminology: nurses with less than one year and greater than ten years of nursing experience 
reported themselves “somewhat confident” with regards to insulin terminology in 100% and 75% 
of responses respectively, compared to the respondents with between 1-10 years of experience, 
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who only rated themselves “somewhat confident” in less than 40% of responses. These results 
indicate that, while new graduate nurses may need greater clinical experience to feel comfortable 
with more complex insulin regimens, nurses with greater than 10 years of experience may 
require refresher courses or continuing education to keep up with changing trends in insulin use 
and changing insulin terminology.   
Continuing education availability may explain comfort differences in insulin terminology 
by shift. Day shift respondents were much more confident with regards to terminology than 
either night or rotating shifts, which may be associated with higher access to in-service education 
and more interaction with rounding provider teams among day shift nurses, though this 
hypothesis would require further investigation to confirm. 
Fear of hypoglycemia and medication administration errors 
 Surveyed nurses consistently indicated that fear of hypoglycemia and fear of making a 
medication error were primary concerns for them with regards to caring for patients receiving 
insulin. While fear of hypoglycemia was identified as a provider-side barrier in previous 
research, fears regarding medication administration errors are unique to nursing staff (Latta et al, 
2011). Results indicate that this fear of errors is particularly prevalent among less experienced 
nurses when compared to their more experienced counterparts. Concerns regarding 
hypoglycemia and medication error related to insulin administration were reported by 69.56% of 
nurses surveyed overall, with higher rates reported from less experienced nurses and those 
working in the Acute Care unit over the Medical/Surgical setting.  
The differences in reported concerns by unit may be explained by how frequently nurses on 
each unit care for patients with diabetes, as well as particular unit priorities and culture. Results 
indicating that less experienced nurses report higher concerns for hypoglycemia/medication error 
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than their more experienced counterparts may indicate that less experienced nurses are more 
likely to feel insecure administering medications in general.  
However, all of these concerns must be examined in the context of how basal-bolus insulin 
(BBI) regimens differ from SSI regimens. BBI administration requires knowledge of and 
confidence with a greater variety of insulin types, and often involves a greater total volume of 
insulin administration per patient when compared to SSI. This makes BBI regimens more 
technically complex for nurses to administer, which increases the potential likelihood of, and 
fear of, making a medication administration error. Similarly, confusion regarding different 
insulins’ uses and when different insulin types should be held or reduced indicates that nurses 
may perceive BBI regimens as more likely to cause hypoglycemia in their patients, despite that 
randomized control trials have shown that BBI dosing does not raise incidence of hypoglycemia 
when compared to SSI use (Datta et al., 2007).  
When considering that nurses are significantly less comfortable with the administration, the 
terminology, and specific indications of BBI insulin types, the fear of hypoglycemia and 
medication errors can be seen as a particularly ‘sharp end’ to many of the individual barriers 
impeding effective BBI protocol administration. These results indicate that further education and 
more explicit insulin administration protocols and policies may improve nurses’ confidence in 
administration of more complex insulin regimes, with the education component acting as an 
essential consideration.  
Factors Unlikely to be Barriers  
Perception of treatment importance 
 Participating nurses overwhelmingly (92%) indicated that they believed that treating 
hyperglycemia was very important, indicating that investment in overall treatment is not likely to 
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be a barrier among nurses to implementing BBI regimens. This can be viewed in contrast to a 
study of provider perceptions, which found that in non-critically ill patients, only 65% of 
providers indicated that treatment of hyperglycemia was ‘very important,’ with the remaining 
35% rating it “somewhat important” (Latta et all, 2011). These results indicate that obtaining 
buy-in on the treatment of hyperglycemia may be easier with nurses than it is with providers, 
since nurses already believe in the importance of managing hyperglycemia. 
 With regards to prevention of hypoglycemia, survey respondents unanimously indicated 
that it was “very important,” and the depth of concern given to hypoglycemia was also reflected 
in responses to qualitative questions, with more than 52% of individual responses involving 
hypoglycemia when asked what their primary concern was for patients receiving insulin. The 
prevalence of hypoglycemia as a chief concern with regard to insulin administration regimens is 
consistent with previous research on providers (Latta et al, 2011; Cheekati et al, 2009).  
Perception of provider interaction 
 Surveyed nurses indicated that they were willing to communicate with providers 
regarding insulin orders, whether for purposes of requesting changes to those orders or 
clarification on dosing and that the providers primarily responded positively to their 
communications. These results indicate that fear of complex provider interactions surrounding 
insulin is unlikely to be a significant nursing barrier, at least within the surveyed population. 
However, the difference between how many surveyed nurses responded that they withheld 
provider feedback and the lack of responses indicating the substance of the feedback and why it 
was withheld was significant enough to warrant further consideration and study. Further, the 
positive nature of surveyed nurses’ perceptions of provider feedback can potentially be attributed 
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to the culture of the medical center or the individual units; therefore, broader study of other 
medical centers may generate different results. 
Indications for future research 
 The survey administered in this study can be considered to be successful in its intended 
objectives, both in providing useful, rich data on potential nursing barriers for further 
investigation, but also in providing data necessary to refine questions for more comprehensive, 
quantitative studies in the future. 
 Confidence questions, which had been previously tested in other similar studies of 
providers, generated comprehensive data from respondents, especially when combined with 
demographic data factors. However, demographic questions require some modification, 
specifically to allow a minimum of respondent self-entry, considering that some demographic 
data was lost due to entries that were too vague, such as answering “inpatient” for unit type 
(Cheekati et al., 2009; Latta et al, 2011). A fully quantitative format would be preferable in 
future studies to gain more consistent, reliable insight. 
 Even with a small sample, trends in responses were identified through nurses’ self-
reporting of concerns and the translation of those concerns into potential barriers. Identified 
barrier categories can be investigated in a more detailed, quantitative manner in future studies by 
examining each category separately, or by allowing nurses to prioritize categories from most to 
least concerning. However, due to the small sample size, further use of this survey on a larger, 
more diverse nursing population would be ideal in order to continue to validate the identified 
categories before they can reliably be used in quantitative research. 
 A potential area of improvement and further investigation is specific perceptions among 
nurses regarding basal insulin and nutritional insulin and their functions. Results identified that 
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many nurses may possess misconceptions about the particular functions and desired protocols for 
each different type of insulin, and more specific questions focused on basal, nutritional, and 
correctional insulins, including confidence measures and skill-type or scenario questions, could 
yield important data in future studies. Additionally, questions related to provider interaction 
yielded behavioral results surrounding administration of different insulin types, and the core of 
these questions could be modified to focus specifically on what requests nurses’ make regarding 
provider orders and why they make them, potentially yielding more complete data that could be 
used to target education. Perceptions of provider feedback could then be addressed in separate 
questions, with provider feedback questions having a subsequent qualifier attached to clarify 
whether nurses were contacting providers regarding BBI insulins, SSI insulin protocols, or both. 
Study limitations 
Small sample size, lack of diversity in sampled groups work locations, and the relatively 
homogenous nature of participants as inpatient nurses working at the same hospital within the 
medical/surgical realm of care were all limitations of this study. Further research based on the 
results of this pilot study will seek to mitigate these potential limitations by including more 
participants and more facilities, and including a larger scope of nursing practice locations, such 
as emergency departments and more specialized units. 
 
Conclusions 
 The results of this study indicate nurses overwhelmingly believe that treating 
hyperglycemia is very important, exceeding provider perceptions of importance indicated by 
prior research. Nurse confidence in BBI administration, fear of hypoglycemia and medication 
errors, and concerns about different insulin types and their specific roles in the treatment of 
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hyperglycemia are all potentially significant nursing staff barriers to the implementation of a BBI 
policy within major medical centers. 
The categorical themes of hypoglycemia, potential medication errors, education, dietary 
intake and meal timing, home versus hospital treatment, and whether the patient was receiving 
the correct treatment were identified from participating nurses’ self-report of their concerns 
regarding insulin administration and hyperglycemia treatment. These themes can be used to 
further refine future quantitative research on larger nurse populations, allowing for more reliable 
data to be collected regarding nursing barriers. 
While more research is necessary, identified themes and potential barriers have clear 
implications for education and policy efforts undertaken by medical centers when attempting to 
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Appendix A – Survey Tool 
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Appendix B – Recruitment Messages
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